Andrew McClory

Title: The Innovative Contributions of Andrew McClory

Introduction

Andrew McClory is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 6 patents to his name, McClory's work has had a substantial impact on medical research and drug development.

Latest Patents

Among his latest patents, McClory has developed solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol. This patent includes processes for preparing fused tricyclic compounds that comprise a substituted phenyl or pyridinyl moiety, along with methods for their use in cancer treatment. Additionally, he has disclosed processes for the preparation of tricyclic PI3K inhibitor compounds, which are designed to be produced in high yield and purity in aqueous solvent systems.

Career Highlights

Throughout his career, McClory has worked with prominent companies in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

McClory has collaborated with esteemed colleagues such as Francis Gosselin and Ngiap-Kie Lim. These partnerships have further enhanced his research capabilities and have led to innovative solutions in the field of cancer treatment.

Conclusion

Andrew McClory's contributions to the pharmaceutical industry through his patents and collaborations highlight his dedication to advancing medical science. His work continues to influence the development of effective treatments for cancer, showcasing the importance of innovation in healthcare.